- Title: Subtitle
- Reply to P.A. Leppäluoto
- Creators
- Anil K. Chaturvedi - Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MDRuth A. Kleinerman - Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MDAllan Hildesheim - Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MDEthel S. Gilbert - Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MDHans Storm - Danish Cancer Society, Copenhagen, DenmarkCharles F. Lynch - University of Iowa, EpidemiologyPer Hall - Karolinska Institutet, Stockholm, SwedenFroydis Langmark - Cancer Registry of Norway, Oslo, NorwayEero Pukkala - Finnish Cancer Registry, Helsinki, FinlandMagnus Kaijser - Karolinska Institutet, Stockholm, SwedenMichael Andersson - Danish Cancer Society, Copenhagen, DenmarkSophie D. Fossa - Cancer Registry of Norway, Oslo, NorwayHeikki Joensuu - Helsinki University Central Hospital, Helsinki, FinlandLois B. Travis - University of Rochester Medical Center, Rochester, NYEric A. Engels - National Institutes of Health
- Resource Type
- Letter/Communication
- Publication Details
- Journal of clinical oncology, Vol.27(18), pp.3066-3067
- DOI
- 10.1200/JCO.2009.22.5706
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Language
- English
- Date published
- 06/20/2009
- Academic Unit
- Epidemiology
- Record Identifier
- 9984214855102771
Letter/Communication
Reply to P.A. Leppäluoto
Journal of clinical oncology, Vol.27(18), pp.3066-3067
06/20/2009
DOI: 10.1200/JCO.2009.22.5706
Details
Metrics
3 Record Views